Works matching DE "FEXOFENADINE"
Results: 279
A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 3, p. 167, doi. 10.1002/hup.2524
- By:
- Publication type:
- Article
Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
- Published in:
- Archives of Dermatological Research, 2015, v. 307, n. 2, p. 183, doi. 10.1007/s00403-014-1525-z
- By:
- Publication type:
- Article
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 4, p. 263, doi. 10.1007/s00403-011-1192-2
- By:
- Publication type:
- Article
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
- Published in:
- Archives of Dermatological Research, 2008, v. 300, n. 6, p. 291, doi. 10.1007/s00403-008-0838-1
- By:
- Publication type:
- Article
Influence of Common Tansy (Tanacetum vulgare) Flower Polysaccharide Complex on P-Glycoprotein Transporter Activity in Vitro.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 53, n. 12, p. 1133, doi. 10.1007/s11094-020-02136-8
- By:
- Publication type:
- Article
Effects of Testosterone on the Functional Activity of P-Glycoprotein.
- Published in:
- Pharmaceutical Chemistry Journal, 2017, v. 51, n. 9, p. 743, doi. 10.1007/s11094-017-1685-1
- By:
- Publication type:
- Article
Developing a method for the quantitative determination of the P-glycoprotein activity marker fexofenadine in blood plasma.
- Published in:
- Pharmaceutical Chemistry Journal, 2006, v. 40, n. 12, p. 686, doi. 10.1007/s11094-006-0220-6
- By:
- Publication type:
- Article
Effficacy and Safety of Fexofenadine and Montelukast Combination Therapy in Allergic Rhinitis Management: A Systematic Review.
- Published in:
- ENT Updates, 2024, v. 14, n. 3, p. 111, doi. 10.54963/entu.v14i3.874
- By:
- Publication type:
- Article
La povertà degli ebrei: Voci dal ghetto. By Luciano Allegra.: Turin: Silvio Zamorani, 2021. Pp. 343. €32.00. ISBN 9788871582504.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
Comparative Study of Bilastine and Fexofenadine in Control of Intermittent Allergic Rhinitis.
- Published in:
- Medica Innovatica, 2022, v. 11, n. 2, p. 62
- By:
- Publication type:
- Article
False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Evaluation of In Vivo P-Glycoprotein Phenotyping Probes.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 4, p. 223, doi. 10.2165/11318000-000000000-00000
- By:
- Publication type:
- Article
Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Synthesis, characterization, and evaluation of differently sulfonated resins as novel carriers for drug delivery.
- Published in:
- Designed Monomers & Polymers, 2013, v. 16, n. 1, p. 56, doi. 10.1080/15685551.2012.705490
- By:
- Publication type:
- Article
FORMULATION AND DEVELOPMENT OF FEXOFENADINE LOADED FAST DISSOLVING FILM.
- Published in:
- Pharma Science Monitor, 2023, v. 14, n. 2, p. 201
- By:
- Publication type:
- Article
FORMULATION, DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING FILM OF FEXOFENADINE FOR THE TREATMENT OF ALLERGIC RHINITIS.
- Published in:
- Pharma Science Monitor, 2018, v. 9, n. 1, p. 429
- By:
- Publication type:
- Article
First experiments with a water‐jet plasma X‐ray source driven by the novel high‐power–high‐repetition rate L1 Allegra laser at ELI Beamlines.
- Published in:
- Journal of Synchrotron Radiation, 2021, v. 28, n. 6, p. 1778, doi. 10.1107/S1600577521008729
- By:
- Publication type:
- Article
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance.
- Published in:
- Journal of Psychopharmacology, 2006, v. 20, n. 4, p. 496, doi. 10.1177/0269881105058362
- By:
- Publication type:
- Article
News Briefs.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 5, p. 374
- Publication type:
- Article
Possible montelukast-induced angioedema.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 23, p. 2284
- By:
- Publication type:
- Article
Acknowledgement to reviewers.
- Published in:
- Archives of Gynecology & Obstetrics, 2022, v. 305, n. 1, p. 293, doi. 10.1007/s00404-021-06391-2
- Publication type:
- Article
Acknowledgement to reviewers.
- Published in:
- Archives of Gynecology & Obstetrics, 2021, v. 303, n. 3, p. 857, doi. 10.1007/s00404-021-05974-3
- Publication type:
- Article
Functioning of P-Glycoprotein during Pregnancy in Rabbits.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2023, v. 174, n. 4, p. 431, doi. 10.1007/s10517-023-05723-3
- By:
- Publication type:
- Article
Effect of Nitric Oxide on the Functioning of the P-Glycoprotein Transporter.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2022, v. 173, n. 1, p. 28, doi. 10.1007/s10517-022-05486-3
- By:
- Publication type:
- Article
Mechanism of As<sub>2</sub>O<sub>3</sub>-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism.
- Published in:
- Toxicological Sciences, 2017, v. 158, n. 2, p. 379, doi. 10.1093/toxsci/kfx098
- By:
- Publication type:
- Article
Updosing antihistamines in chronic spontaneous urticaria.
- Published in:
- Geneesmiddelenbulletin, 2022, n. 11, p. 1
- By:
- Publication type:
- Article
Fabrication and Validation of Novel Fexofenadine Sensor using Alizarin Red S as Ion Exchanger on PVC Matrix for Assay in Pharmaceuticals and Spiked Human Urine Samples.
- Published in:
- Analytical & Bioanalytical Electrochemistry, 2022, v. 14, n. 10, p. 934
- By:
- Publication type:
- Article
Determination of cetirizine and its impurities in bulk and tablet formulation using a validated capillary zone electrophoretic method.
- Published in:
- Journal of Analytical Chemistry, 2014, v. 69, n. 5, p. 442, doi. 10.1134/S1061934814050037
- By:
- Publication type:
- Article
Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials.
- Published in:
- BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s40360-019-0363-1
- By:
- Publication type:
- Article
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail.
- Published in:
- Journal of Personalized Medicine, 2019, v. 9, n. 4, p. 45, doi. 10.3390/jpm9040045
- By:
- Publication type:
- Article
H<sub>1</sub>-antihistamines and urticaria: how can we predict the best drug for our patient?
- Published in:
- Clinical & Experimental Allergy, 2012, v. 42, n. 10, p. 1423, doi. 10.1111/j.1365-2222.2012.03957.x
- By:
- Publication type:
- Article
Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.
- Published in:
- Psychopharmacology, 2006, v. 187, n. 1, p. 95, doi. 10.1007/s00213-006-0406-3
- By:
- Publication type:
- Article
Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin‐31 levels in mild to moderate paediatric atopic dermatitis.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 4, p. 724, doi. 10.1111/ced.15032
- By:
- Publication type:
- Article
Flexural follicular lichen planus.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Efficacy of Loratadine Compared with Fexofenadine or Placebo for the Treatment of Seasonal Allergic Rhinitis.
- Published in:
- Clinical Drug Investigation, 2001, v. 21, n. 8, p. 571, doi. 10.2165/00044011-200121080-00006
- By:
- Publication type:
- Article
Long-Term Tolerability of Fexofenadine in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 1999, v. 18, n. 4, p. 317, doi. 10.2165/00044011-199918040-00008
- By:
- Publication type:
- Article
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2022, v. 15, p. 261, doi. 10.2147/CCID.S350122
- By:
- Publication type:
- Article
In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2002, v. 16, n. 4, p. 421, doi. 10.1046/j.1468-3083.2002.00570_8.x
- By:
- Publication type:
- Article
The Effects of Fexofenadine at Steady-State on Sleep Architecture.
- Published in:
- Annals of Indian Academy of Neurology, 2008, v. 11, p. S148
- By:
- Publication type:
- Article
ISMP Adverse Drug Reactions: Propofol-Related Infusion Syndrome (PRIS)<sup>1,2</sup>; Ivermectin-Induced Stevens-Johnson Syndrome; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis From Fexofenadine; Memantine-Related Drug Eruption.
- Published in:
- Hospital Pharmacy, 2018, v. 53, n. 4, p. 220, doi. 10.1177/0018578718776857
- By:
- Publication type:
- Article
In Vivo Alterations in Drug Metabolism and Transport Pathways in Patients with Chronic Kidney Diseases.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 2, p. 114, doi. 10.1002/phar.1347
- By:
- Publication type:
- Article
Echinacea purpurea Significantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir-Ritonavir Exposure in Healthy Subjects.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 8, p. 797, doi. 10.1592/phco.30.8.797
- By:
- Publication type:
- Article
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2005, v. 20, n. 7, p. 501, doi. 10.1002/hup.713
- By:
- Publication type:
- Article
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d -chlorpheniramine and placebo on psychomotor function in healthy volunteers.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2003, v. 18, n. 8, p. 611, doi. 10.1002/hup.538
- By:
- Publication type:
- Article
Management of Peyronie's disease – a review.
- Published in:
- World Journal of Urology, 2001, v. 19, n. 4, p. 244, doi. 10.1007/s003450100209
- By:
- Publication type:
- Article
Paul-Peter Tak, Academic Medical Center, University of Amsterdam, The Netherlands (ed): New Therapeutic Targets in Rheumatoid Arthritis. (PIR: Progress in Inflammation Research Series).
- Published in:
- 2010
- By:
- Publication type:
- Book Review
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber.
- Published in:
- Inflammation Research, 2010, v. 59, n. 5, p. 391, doi. 10.1007/s00011-009-0117-4
- By:
- Publication type:
- Article
Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers.
- Published in:
- Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 3, p. 274, doi. 10.1111/jphp.12687
- By:
- Publication type:
- Article
The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
- Published in:
- Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 6, p. 773, doi. 10.1111/jphp.12374
- By:
- Publication type:
- Article